Expertise in
4
conditions

Bertille Bonniaud

Dijon, FR 
Expertise in
4
conditions
Dijon, FR 

Overview

Bertille Bonniaud practices practicing medicine in Dijon, France.

Ms. Bonniaud is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Hypertrichosis Lanuginosa Congenita, Hypomelanosis of Ito, Ambras Syndrome, and Giant Congenital Melanocytic Nevus.

She is actively involved in clinical research, co-authoring 30 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

Dijon, France
Other Locations
Paris, France
CHU Rennes
Rennes, 35000, France
Bourgogne, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children and Adults: a Cluster Multicenter Randomized Trial
Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children and Adults: a Cluster Multicenter Randomized Trial
Enrollment Status: Completed
Publish Date: June 17, 2024
Intervention Type: Drug
Study Drugs: Ivermectin, Permethrin
Study Phase: Phase 3
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: November 30, 2022
Intervention Type: Biological, Other
Study Drug: Lebrikizumab
Study Phase: Phase 3
View 2 Less Clinical Trials

30 Total Publications

National qualitative study in France to explore parents' lived experience at the birth of a child with a large or giant congenital melanocytic nevus.
National qualitative study in France to explore parents' lived experience at the birth of a child with a large or giant congenital melanocytic nevus.
Journal: BMJ open
Published: July 08, 2026

Frequently Asked Questions about Bertille Bonniaud

Is Bertille Bonniaud a top-rated expert for Hypertrichosis Lanuginosa Congenita?

MediFind is an objective health platform that identifies experts based on real-world data. Bertille Bonniaud is classified as an Advanced expert for Hypertrichosis Lanuginosa Congenita, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Bertille Bonniaud participate in research or clinical trials?

Yes. Bertille Bonniaud has published 30 articles and abstracts on conditions like Hypertrichosis Lanuginosa Congenita. You can view a list of Bertille Bonniaud's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Bonniaud's expertise for a condition
ConditionClose
      View All 26 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile